Pegaltevir

About Pharmapark

Pharmapark is a private, revenue-generating Russian biopharmaceutical company established in 2003, operating as a full-cycle developer and manufacturer of biological drugs. It has a diversified business model combining proprietary in-house product development with extensive contract manufacturing and localization services for international partners. The company's strategy leverages its GMP-certified production facilities, R&D center, and a network of global partnerships to bring both generic and original biologics to the Russian market and beyond.

Therapeutic Areas